SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-194796
Filing Date
2019-07-16
Accepted
2019-07-16 16:24:30
Documents
8
Effectiveness Date
2019-07-16

Document Format Files

Seq Description Document Type Size
1 S-8 d772706ds8.htm S-8 70135
2 EX-5.1 d772706dex51.htm EX-5.1 5751
3 EX-23.1 d772706dex231.htm EX-23.1 6257
4 EX-99.2 d772706dex992.htm EX-99.2 168436
5 EX-99.3 d772706dex993.htm EX-99.3 118462
6 EX-99.4 d772706dex994.htm EX-99.4 46160
7 GRAPHIC g772706g35u99.gif GRAPHIC 2304
8 GRAPHIC g772706g42a76.jpg GRAPHIC 24406
  Complete submission text file 0001193125-19-194796.txt   453407
Mailing Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008
Business Address 60 AVENUE ROCKEFELLER BATIMENT ADENINE LYON I0 69008 011-33-4-78-74-44-38
Erytech Pharma S.A. (Filer) CIK: 0001624422 (see all company filings)

IRS No.: 000000000 | State of Incorp.: I0 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232670 | Film No.: 19957408
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences